Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Switzerland

Switzerland Articles

Industry

Switzerland-based Actelion, Europe's biggest biotech company, achieved a 20% increase in revenues in 2009, to US$1.65bn from US$1.37bn in 2008, aided by the strong sales of its top-selling... 2010-02-22


Industry

US based Cephalon is to acquire Swiss generic drugmaker Mepha AG and its subsidiaries from the family of the late German billionaire Adolf Merckle for US$590mn. The transaction is... 2010-02-04


Industry

Swiss drugmaker Roche has posted strong results for 2009, highlighting the opportunities that pandemics such as swine flu can provide to drug companies. The company has reported... 2010-02-03


More ARTICLES

Industry

Despite the economic downturn, Swiss drugmaker Novartis has posted a strong set of results for the financial year ending 2009, with record sales in the company's pharmaceutical division... 2010-01-27


Industry

Multinational dug company Roche is investing approximately CHF1.90bn (US$1.82bn) in manufacturing a novel device that will allow patients to self-administer biological cancer medicines.... 2010-01-21


Industry

Merck Serono has become the latest multinational to establish a major research and development (R&D) facility in China. The Geneva-headquartered firm will leverage the country's... 2009-11-25


Industry

With the aim of banning doctors in Switzerland dispensing medicines, the country's government has approved the amendment of the Heilmittelgesetz, a law that has regulated the distribution... 2009-11-20


Industry

A study carried out by Swiss pharmaceutical industry and health insurance companies has revealed that the country's citizens pay significantly higher prices for generic medicines... 2009-11-19

Western Europe InsightWestern Europe Channels Western Europe Countries